CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 250 enrolled
Drug / intervention
ACR | U.S. Urine Analysis Test System +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04626271
NCT04626271N/ACompleted

Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands

Healthy.io Ltd.·interventional·Posted Nov 12, 2020·Updated May 9, 2023

In Brief

A clinical study evaluating ACR | U.S. Urine Analysis Test System and URiSCAN Optima Urine Analyzer for Albuminuria. Completed, enrolled 250 participants across 2 sites.

Detailed Summary

Eligible subjects meeting the pathological profile will be recruited at the designated site by the study personnel. Following subject consent, the subjects will be evaluated for eligibility based on their health condition and history. The ACR \| U.S. kit, in its original packaging, along with the ACR \| U.S. smartphone application will be provided to the subject in a simulated home- use environment. All subjects will be provided with a list of tasks to complete, including providing a urine sample and operating the ACR \| U.S. device on 2 mobile phones. After completing the test, the lay user will complete a post-test questionnaire. The study observer will also complete a questionnaire to collect information regarding the lay users' use of the ACR \| U.S. The device use will be compared with identified risks to determine if the percentage of failures is acceptable. Additionally, measurable usability criteria for specific, critical steps will be evaluated. Following the usability test performed by the lay user, the subjects' urine samples will be tested by the study staff using the comparator device. These results will be considered as the "true value".

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlbuminuria
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 12, 2020
Enrollment StartAug 31, 2020
Primary CompletionOct 23, 2020
Study CompletionOct 25, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.6 years ago

Interventions

ACR | U.S. Urine Analysis Test Systemdevice

Each study participant will test their urine sample using the ACR \| U.S. test device - a home-use device intended for the semi-quantitative measurement of ACR in the urine (albumin and creatinine ratio) and used to aid in the management of kidney health.

URiSCAN Optima Urine Analyzerdevice

Upon completion of the test using the ACR \| U.S. device, each urine sample will be provided to a professional user for further urine analysis test using the comparator device, the URiSCAN Optima Urine Analyzer.